The Role of PET-FDG in Resolving Diagnostic Doubt: Recurrence vs. Radionecrosis in Brain Tumors

Abstract

Keywords

brain tumors recurrence radionecrosis PET

Get full access to this article

View all access options for this article.

References

Taylor

Langston

: Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys: 36, 1251–1261, 1996.

DiChiro

Oldfield

: Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. Am J Roentgenol: 150, 189–197, 1988.

Mineura

Sasajima

: Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73: 2386–2394, 1994.

Valk

Dillon

. Radiation injury of the brain. Am J Neuroradiol 12: 45–62, 1991.

Schwartz

Carvalho

: Radiation necrosis vs high grade recurrent glioma: differentiation by using dual isotope SPECT 201-Tl and Tc-HMPAO. AmJ Roentgenol 158: 399–404, 1992.

Derlon

Petit-Taboué

: The in vivo metabolic pattern of low-grade brain gliomas: a PET study using FDG and 11-C-L-methylmetionine. Neurosurgery 40: 277–288, 1997.

Fischman

Thorton

: FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma. J Nucl Med 38: 1027–1029, 1997.

Nelson

Day

: Alignment of volume MR images and high resolution FDG PET images for the evaluation of patients with brain tumors. J Comput Assist Tomogr 21: 183–191, 1997.

Buchpingel

Alavi

: Comparison of PET-FDG and SPECT 201-Tl in distinguishing radiation necrosis from tumor recurrence in the brain. J Nucl Med 38: 906 22P., 1997.

10.

Maldonado

Calvo

: A-portación de la PET-FDG al diagnóstico diferencial recidiva vs radionecrosis en tumores cerebrales. Oncología PS1-68: 104P., 1997.